BioLargo Comprehensive Income 2010-2024 | BLGO
BioLargo comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
BioLargo Annual Comprehensive Income
(Millions of US $) |
| 2023 |
$-0 |
| 2022 |
$-0 |
| 2021 |
$-0 |
| 2020 |
$-0 |
| 2019 |
$-0 |
| 2018 |
$-0 |
| 2017 |
$-0 |
| 2016 |
$-0 |
| 2015 |
$-0 |
| 2014 |
$ |
| 2013 |
$ |
| 2012 |
$ |
| 2011 |
$ |
| 2010 |
$ |
| 2009 |
$ |
BioLargo Quarterly Comprehensive Income
(Millions of US $) |
| 2024-09-30 |
$-0 |
| 2024-06-30 |
$-0 |
| 2024-03-31 |
$-0 |
| 2023-12-31 |
$-0 |
| 2023-09-30 |
$-0 |
| 2023-06-30 |
$-0 |
| 2023-03-31 |
$-0 |
| 2022-12-31 |
$-0 |
| 2022-09-30 |
$-0 |
| 2022-06-30 |
$-0 |
| 2022-03-31 |
$-0 |
| 2021-12-31 |
$-0 |
| 2021-09-30 |
$-0 |
| 2021-06-30 |
$-0 |
| 2021-03-31 |
$-0 |
| 2020-12-31 |
$-0 |
| 2020-09-30 |
$-0 |
| 2020-06-30 |
$-0 |
| 2020-03-31 |
$-0 |
| 2019-12-31 |
$-0 |
| 2019-09-30 |
$-0 |
| 2019-06-30 |
$-0 |
| 2019-03-31 |
$-0 |
| 2018-12-31 |
$-0 |
| 2018-09-30 |
$-0 |
| 2018-06-30 |
$-0 |
| 2018-03-31 |
$-0 |
| 2017-12-31 |
$-0 |
| 2017-09-30 |
$-0 |
| 2017-06-30 |
$-0 |
| 2017-03-31 |
$-0 |
| 2016-12-31 |
$-0 |
| 2016-09-30 |
$-0 |
| 2016-06-30 |
$-0 |
| 2016-03-31 |
$-0 |
| 2015-12-31 |
$-0 |
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
|
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
|
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
|
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
|
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
|
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Construction |
Engineering - Research & Development Services |
$0.054B |
$0.012B |
|
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
|
